Strategic Investment Advisors’s ResMed RMD Stock Holding History

Strategic Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,230	Closed	-$276K	–	418
2026 Q1	$276K	Buy	+1,230	New	+$307K	0.02%	272

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Strategic Investment Advisors's RMD Position: Q2 2026 in Review

Strategic Investment Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,230 shares — an estimated $276K sold.

Strategic Investment Advisors first reported a position in RMD in Q1 2026 and held it in 1 quarter. The position peaked at $276K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Strategic Investment Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Strategic Investment Advisors sold 1,230 ResMed shares in Q2 2026, an estimated $276K.
Strategic Investment Advisors first reported a position in ResMed in Q1 2026 and held it in 1 quarter.
Strategic Investment Advisors's ResMed position peaked at $276K in Q1 2026.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Strategic Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.